Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

BACKGROUND: The bile acid-activated nuclear receptor Farnesoid X Receptor (FXR) is critical in maintaining intestinal barrier integrity and preventing bacterial overgrowth. Patients with Crohn's colitis (CC) exhibit reduced ileal FXR target gene expression. FXR agonists have been shown to ameli...

Full description

Bibliographic Details
Main Authors: Fiona D M van Schaik, Raffaella M Gadaleta, Frank G Schaap, Saskia W C van Mil, Peter D Siersema, Bas Oldenburg, Karel J van Erpecum
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3506649?pdf=render

Internet

http://europepmc.org/articles/PMC3506649?pdf=render

Similar Items